[550 Pages Report] The global infection control market is projected to reach USD 52.7 billion by 2026, at a CAGR of 3.4% during the forecast period. Growth in this market can largely be attributed to factors such as the increasing number of surgical procedures; the high incidence of hospital-acquired infections; the growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. 

Currently, with the surge in cases of COVID-19, there is an increasing focus on personal hygiene and increasing production of medical nonwovens and single-use products, such as face masks and gloves. This, in turn, is expected to propel market growth in the next two years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years.  

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084 

The COVID-19 outbreak has made personal and household disinfection increasingly important to prevent the spread of the disease. Cleaning product companies ramped up production, resulting in volume increases of sanitizer products upward of 60% (Source: American Cleaning Institute, 2020). Equipment sterilization plays a critical role in preventing the spread of COVID-19 in healthcare settings. During the outbreak, patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilizing medical devices. 

According to the National Center for Biotechnology Information (NCBI, US), there has been a significant increase in the number of surgical procedures in the US over the last decade, and this trend is expected to continue in the coming years. The American Society of Plastic Surgeons (ASPS) released its annual plastic surgery procedural statistics, reporting that 1.8 million surgical cosmetic procedures and 15.9 million minimally invasive cosmetic procedures were performed in the US in 2019; this represented an increase of 2% and 1% over the procedures conducted in 2017. 

Thus, with growth in the number of surgeries, the need for infection control is also increasing as improper sterilization of equipment used in surgical procedures or inadequately disinfected hospitals/clinics could lead to growth in the number of HAI and SSI cases. This is expected to play a key role in the greater uptake of infection control technologies in the coming years, propelling the growth of the market during the forecast period. 

The prominent players in infection control market are STERIS plc. (US), Getinge AB (Sweden), Cantel Medical Corporation (US), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), MMM Group (Germany), MATACHANA GROUP (Spain), Sotera Health LLC (US), Ecolab, Inc. (US), Metrex Research Corporation (US), Reckitt Benckiser Group Plc. (UK), Miele Group (Germany), Melag (Germany), and Pal International (UK).